ERCC3 and cancer: These loss-of-function genetic screens have allowed investigating cellular drug mechanism-of-action in cancer cell lines15 as well as the identification of potential therapeutic targets like the DNA repair helicase WRN, a synthetic lethal vulnerability and promising target in cancers with microsatellite instability16.